Labeler
Zydus Pharmaceuticals USA Inc. NDC Codes
Zydus Pharmaceuticals USA Inc. lists 629 finished drug products in the FDA NDC Directory under NDC labeler codes 68382, 70710.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Riociguat, brivaracetam, tofacitinib, Eltrombopag, Beizray, Carbidopa and Levodopa, Jaythari, Deflazacort, Ascorbic acid, gadobutrol, Verapamil hydrochloride, Diazepam, gabapentin, oxcarbazepine
- Active ingredients
- Deflazacort, Isotretinoin, Riociguat, Brivaracetam, Tofacitinib citrate, Eltrombopag olamine, Carbidopa, Levodopa, Ascorbic acid, Gadobutrol, Verapamil hydrochloride, Diazepam
- NDC labeler codes
- 68382, 70710
- Strengths (from the 100 most recently listed products)
- Ascorbic acid 500 mg/mL; Gadobutrol 604.72 mg/mL; Docetaxel anhydrous 20 mg/mL; Deflazacort 22.75 mg/mL; Deflazacort 6 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Riociguat .5 mg/1; Riociguat 1 mg/1; Riociguat 1.5 mg/1; Riociguat 2 mg/1; Riociguat 2.5 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Tofacitinib citrate 10 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Injection, Solution, Capsule, Capsule, Extended release, Kit, Gel, Tablet, Extended release, Tablet, Film coated, Extended release, Suspension, Liquid, Tablet, For suspension, Powder, For solution
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intravitreal
- Drug classes (FDA established)
- Corticosteroid, Serotonin Reuptake Inhibitor, Retinoid, Soluble Guanylate Cyclase Stimulator, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Aromatic Amino Acid, Anti-epileptic Agent, Vitamin C, Gadolinium-based Contrast Agent, Calcium Channel Blocker, Benzodiazepine, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Tetracycline-class Drug, Vascular Endothelial Growth Factor Inhibitor, Diagnostic Dye, Nitrogen Binding Agent, Sodium-Glucose Cotransporter 2 Inhibitor, Endothelin Receptor Antagonist, Microtubule Inhibitor, CCR5 Co-receptor Antagonist, Kinase Inhibitor, Calcitonin, Oxidation-Reduction Agent, Phosphate Binder, Xanthine Oxidase Inhibitor, Arteriolar Vasodilator, Enzyme Stabilizer, Glucosylceramide Synthase Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 169 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Colchicine | Colchiceine .6 mg/1 | TabletOral | 70710-1351 | 70710-1351-0170710-1351-0370710-1351-05+1 more | — |
| esomeprazole magnesium | Esomeprazole magnesium dihydrate 20 mg/1 | Capsule, Delayed releaseOral | 68382-441 | 68382-0441-0668382-0441-1068382-0441-16 | — |
| esomeprazole magnesium | Esomeprazole magnesium dihydrate 40 mg/1 | Capsule, Delayed releaseOral | 68382-442 | 68382-0442-0668382-0442-1068382-0442-16 | — |
| Chlorthalidone | Chlorthalidone 25 mg/1 | TabletOral | 68382-970 | 68382-0970-0168382-0970-10 | — |
| Chlorthalidone | Chlorthalidone 50 mg/1 | TabletOral | 68382-971 | 68382-0971-0168382-0971-10 | — |
| acetazolamide | Acetazolamide 500 mg/1 | CapsuleOral | 70710-1591 | 70710-1591-0070710-1591-0170710-1591-03+3 more | — |
| Bosentan | Bosentan 62.5 mg/1 | Tablet, CoatedOral | 68382-446 | 68382-0446-0168382-0446-0568382-0446-14+2 more | — |
| Bosentan | Bosentan 125 mg/1 | Tablet, CoatedOral | 68382-447 | 68382-0447-0168382-0447-0568382-0447-14+2 more | — |
| leflunomide | Leflunomide 10 mg/1 | Tablet, Film coatedOral | 70710-1157 | 70710-1157-0170710-1157-0370710-1157-05 | — |
| leflunomide | Leflunomide 20 mg/1 | Tablet, Film coatedOral | 70710-1158 | 70710-1158-0170710-1158-0370710-1158-05 | — |
| Ambrisentan | Ambrisentan 5 mg/1 | Tablet, Film coatedOral | 70710-1179 | 70710-1179-0170710-1179-0370710-1179-07+2 more | — |
| Ambrisentan | Ambrisentan 10 mg/1 | Tablet, Film coatedOral | 70710-1180 | 70710-1180-0170710-1180-0370710-1180-07+2 more | — |
| Triamterene and Hydrochlorothiazide | Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1 | CapsuleOral | 68382-855 | 68382-0855-0168382-0855-0568382-0855-10+1 more | — |
| Tadalafil | Tadalafil 2.5 mg/1 | Tablet, Film coatedOral | 68382-896 | 68382-0896-0168382-0896-0568382-0896-06+3 more | — |
| Tadalafil | Tadalafil 5 mg/1 | Tablet, Film coatedOral | 68382-897 | 68382-0897-0168382-0897-0568382-0897-06+4 more | — |
| Tadalafil | Tadalafil 10 mg/1 | Tablet, Film coatedOral | 68382-898 | 68382-0898-0168382-0898-0568382-0898-06+3 more | — |
| Tadalafil | Tadalafil 20 mg/1 | Tablet, Film coatedOral | 68382-899 | 68382-0899-0168382-0899-0568382-0899-06+3 more | — |
| carbamazepine | Carbamazepine 100 mg/1 | Tablet, Extended releaseOral | 68382-555 | 68382-0555-0168382-0555-0668382-0555-16+1 more | — |
| carbamazepine | Carbamazepine 200 mg/1 | Tablet, Extended releaseOral | 68382-556 | 68382-0556-0168382-0556-0668382-0556-16+1 more | — |
| carbamazepine | Carbamazepine 400 mg/1 | Tablet, Extended releaseOral | 68382-557 | 68382-0557-0168382-0557-0668382-0557-16+1 more | — |
| Atenolol and Chlorthalidone | Atenolol 50 mg/1; Chlorthalidone 25 mg/1 | TabletOral | 70710-1167 | 70710-1167-01 | — |
| Atenolol and Chlorthalidone | Atenolol 100 mg/1; Chlorthalidone 25 mg/1 | TabletOral | 70710-1168 | 70710-1168-01 | — |
| Clindamycin Phosphate and Benzoyl Peroxide | Clindamycin phosphate 10 mg/g; Benzoyl peroxide 50 mg/g | GelTopical | 70710-1445 | 70710-1445-04 | — |
| Rivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | 70710-1196 | 70710-1196-07 | — |
| Rivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | 70710-1197 | 70710-1197-07 | — |
| Rivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | 70710-1198 | 70710-1198-07 | — |
| Betamethasone dipropionate | Betamethasone dipropionate .5 mg/g | CreamTopical | 70710-1233 | 70710-1233-0170710-1233-04 | — |
| Phytonadione | Phytonadione 5 mg/1 | TabletOral | 70710-1014 | 70710-1014-0170710-1014-0370710-1014-04 | — |
| fondaparinux sodium | Fondaparinux sodium 2.5 mg/.5mL | Injection, SolutionSubcutaneous | 70710-1514 | 70710-1514-0670710-1514-09 | — |
| fondaparinux sodium | Fondaparinux sodium 5 mg/.4mL | Injection, SolutionSubcutaneous | 70710-1515 | 70710-1515-0670710-1515-09 | — |
| fondaparinux sodium | Fondaparinux sodium 7.5 mg/.6mL | Injection, SolutionSubcutaneous | 70710-1516 | 70710-1516-0670710-1516-09 | — |
| fondaparinux sodium | Fondaparinux sodium 10 mg/.8mL | Injection, SolutionSubcutaneous | 70710-1517 | 70710-1517-0670710-1517-09 | — |
| Gemfibrozil | Gemfibrozil 600 mg/1 | TabletOral | 68382-553 | 68382-0553-0168382-0553-0568382-0553-06+4 more | — |
| Baclofen | Baclofen 10 mg/1 | TabletOral | 70710-1285 | 70710-1285-0070710-1285-0170710-1285-05 | — |
| Baclofen | Baclofen 20 mg/1 | TabletOral | 70710-1286 | 70710-1286-0070710-1286-0170710-1286-05 | — |
| Lansoprazole | Lansoprazole 15 mg/1 | Tablet, Orally disintegratingOral | 68382-771 | 68382-0771-77 | — |
| Lansoprazole | Lansoprazole 30 mg/1 | Tablet, Orally disintegratingOral | 68382-772 | 68382-0772-77 | — |
| acyclovir | Acyclovir sodium 50 mg/mL | Injection, SolutionIntravenous | 68382-048 | 68382-0048-10 | — |
| acyclovir | Acyclovir sodium 50 mg/mL | Injection, SolutionIntravenous | 68382-049 | 68382-0049-10 | — |
| Arsenic trioxide | Arsenic trioxide 1 mg/mL | Injection, SolutionIntravenous | 68382-997 | 68382-0997-10 | — |
| Ursodiol | Ursodiol 250 mg/1 | TabletOral | 70710-1127 | 70710-1127-0170710-1127-05 | — |
| Ursodiol | Ursodiol 500 mg/1 | TabletOral | 70710-1128 | 70710-1128-0170710-1128-05 | — |
| Vardenafil | Vardenafil hydrochloride trihydrate 2.5 mg/1 | Tablet, Film coatedOral | 70710-1068 | 70710-1068-0170710-1068-0370710-1068-09 | — |
| Vardenafil | Vardenafil hydrochloride trihydrate 5 mg/1 | Tablet, Film coatedOral | 70710-1069 | 70710-1069-0170710-1069-0370710-1069-09 | — |
| Vardenafil | Vardenafil hydrochloride trihydrate 10 mg/1 | Tablet, Film coatedOral | 70710-1070 | 70710-1070-0170710-1070-0370710-1070-09 | — |
| Vardenafil | Vardenafil hydrochloride trihydrate 20 mg/1 | Tablet, Film coatedOral | 70710-1071 | 70710-1071-0170710-1071-0370710-1071-09 | — |
| Fluocinonide | Fluocinonide .5 mg/mL | SolutionTopical | 70710-1284 | 70710-1284-0370710-1284-08 | — |
| Exemestane | Exemestane 25 mg/1 | TabletOral | 68382-383 | 68382-0383-06 | — |
| Carbidopa | Carbidopa 25 mg/1 | TabletOral | 70710-1221 | 70710-1221-01 | — |
| triamterene and hydrochlorothiazide | Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | 68382-856 | 68382-0856-0168382-0856-0568382-0856-10+1 more | — |
Zydus Pharmaceuticals USA Inc.: common questions
- What is Zydus Pharmaceuticals USA Inc.'s NDC labeler code?
- 68382, 70710. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.